FDA MedWatch - Hyperbaric Oxygen Therapy: Get the Facts

MedWatch - The FDA Safety Information and Adverse Event Reporting Program Hyperbaric Oxygen Therapy: Get the Facts The U.S. Food and Drug Administration (FDA) has cleared the use of Hyperbaric Oxygen Therapy (HBOT) for the treatment of several conditions. The FDA is aware there are some hyperbaric oxygen treatment centers promoting hyperbaric oxygen chambers for uses that have not been cleared or approved by the FDA, such as treatment of cancer, Lyme disease, autism, or Alzheimer's disease. Check with your health care provider before using HBOT to make sure you are pursuing the most appropriate care. If your health care provider recommends HBOT, the FDA advises you get the treatment at a hospital or facility that has been inspected and is accredited by the Undersea and Hyperbaric Medical Society. Questions? If you have experienced a problem or injury that you think may be related to a hyperbaric oxygen therapy, you can voluntarily report it through the FDA's MedWatch program.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA